About IBA
IBA is a company based in Louvain-la-neuve (Belgium) founded in 1986 by Yves Jongen. It operates as a Professional Services and Direct-to-Consumer (D2C). IBA has raised $27.32 million across 11 funding rounds from investors including European Union, SRIW and SFPIM. The company has 26 employees as of March 28, 2024. IBA has completed 3 acquisitions, including Modus QA, PhantomX and Radcal. IBA offers products and services including Proton Therapy, Dosimetry Solutions, RadioPharma Solutions, and Industrial Solutions. IBA operates in a competitive market with competitors including Oxford Instruments, Nanox, Leica Microsystems, SpectraWAVE and Adaptix, among others.
- Headquarter Louvain-la-neuve, Belgium
- Employees 26 as on 28 Mar, 2024
- Founders Yves Jongen
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iba Worldwide
- Date of Incorporation 24 Dec, 2004
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$4.73 M (USD)23.52as on Mar 31, 2023
-
Net Profit
$692.78 K (USD)54.63as on Mar 31, 2023
-
EBITDA
$1.05 M (USD)51.05as on Mar 31, 2023
-
Total Equity Funding
$27.32 M (USD)
in 11 rounds
-
Latest Funding Round
$260.73 K (USD), Grant
Nov 16, 2021
-
Investors
European Union
& 2 more
-
Employee Count
26
as on Mar 28, 2024
-
Investments & Acquisitions
Modus QA
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IBA
IBA offers a comprehensive portfolio of products and services, including Proton Therapy, Dosimetry Solutions, RadioPharma Solutions, and Industrial Solutions.
Advanced cancer treatment using proton beam technology is provided.
Quality assurance tools for radiation therapy are offered.
Radiochemistry and cyclotron solutions for diagnostics are developed.
Sterilization solutions for medical devices are engineered.
People of IBA
Unlock access to complete
Unlock access to complete
Software Development Team
56 people
Product Management Team
27 people
R Team
23 people
Leadership Team
20 people
Field Team
15 people
Human Resources and Administration
14 people
Sales and Marketing
11 people
Creative and Marketing Team
9 people
Unlock access to complete
Funding Insights of IBA
IBA has successfully raised a total of $27.32M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $260.73 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IBA
IBA has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SRIW and SFPIM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Buyouts are pursued by SRIW as a private equity firm.
|
Locked | Locked | Locked | |
|
Private equity is directed toward private and public companies.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for IBA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IBA
IBA has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Modus QA, PhantomX and Radcal.
Investment portfolio details for IBA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provides realistic phantoms for medical imaging, AI training, and diagnostic testing.
|
Locked | Locked | 2021 | Locked | |
|
Advanced radiotherapy and medical imaging devices are manufactured.
|
Locked | Locked | 2000 | Locked | |
|
Diagnostic X-ray imaging solutions are provided for medical practitioners.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for IBA
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - IBA
Detailed financials for IBA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iba Comparisons
Peer comparison for IBA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IBA
IBA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Nanox, Leica Microsystems, SpectraWAVE and Adaptix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology tools and systems for molecular scale are developed.
|
|
| Locked | Locked | Locked |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
|
|
| Locked | Locked | Locked |
Imaging solutions for macro, micro, and nano structures are provided.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Planar X-ray radiology products for diagnostic imaging are supplied.
|
Detailed competitors of IBA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iba
Complete news archive for IBA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IBA
IBA was founded in 1986 and raised its 1st funding round 28 years after it was founded.
IBA is headquartered in Louvain-la-neuve, Belgium.
IBA is a funded company, having raised a total of $27.32M across 11 funding rounds to date.
As of Mar 28, 2024, the latest employee count at IBA is 26.
Annual revenue of IBA is $4.73M as on Mar 31, 2023.
Solutions for cancer diagnosis and treatment are designed and marketed by IBA, focusing on proton therapy and dosimetry. Industrial applications such as medical device sterilization are also addressed. Sectors including healthcare and industrial technology are served with advanced equipment and services. Integrated radiopharma solutions and cyclotrons are developed for medical imaging and diagnostics. Sustainability and scientific innovation are emphasized through the IBA Discovery Lab.
IBA's top competitors include Oxford Instruments, Adaptix and Nanox.
IBA offers Proton Therapy, Dosimetry Solutions, RadioPharma Solutions, and Industrial Solutions.
IBA has 3 investors. Key investors include European Union, SRIW, and SFPIM.